Presentation previews · Artwork labels are not verified filling specifications. Purchasing is not available.

AEVIA MED / VIALS
NAD+
Cellular coenzyme involved in oxidation–reduction reactions. NAD+ vial artwork is separate from the NAD+ pen.
Price
Price to confirm
Presentation status
Supplied visual concept. The printed amount is an artwork reference, not confirmation of AEVIA filling, formulation, physical state or use. It is not an application dose.
Compound identity and research context · Separate from the exact product specification
What it is
NAD+ is a coenzyme, not a peptide. It participates in cellular redox chemistry.
Biological target / research area
Cellular metabolism and NAD-related pathways.
What the research examined
Evidence context: human metabolism pilot
A small human pilot examined plasma and urine metabolites during an intravenous infusion.
Evidence limitations
This metabolic study does not establish anti-ageing, energy or cognitive benefits from AEVIA vials or pens. Precursor supplement studies are not interchangeable with NAD+ injections.
NAD+ · 500 mg: this printed quantity identifies the artwork presentation. It is not a verified filling specification or an application dose.
Selected references
- Pilot investigation of plasma and urine NAD+ metabolites during infusion (2019) ↗ · Reviewed 14/10/2026
Composition & specification
Verified product specifications and release documentation are pending. No dosing, preparation or administration instructions are provided.
Storage, safety & batch information
Product-specific storage, expiry and safety documentation must be confirmed for the exact released presentation. Use the exact-presentation batch reference lookup in the product guide. A record match does not authenticate physical contents.